What is BlueDot?
BlueDot is at the forefront of protecting populations worldwide from infectious diseases, leveraging a sophisticated blend of human expertise and artificial intelligence. The company provides critical solutions for governments, hospitals, and businesses, enabling them to anticipate, track, and contextualize infectious disease risks. By integrating medical and public health knowledge with advanced data analytics, BlueDot offers a robust platform designed to safeguard citizens, healthcare professionals, patients, employees, and customers.
How much funding has BlueDot raised?
BlueDot has raised a total of $7M across 1 funding round:
Series A
$7M
Series A (2019): $7M with participation from The Co-operators, BDC Capital, and Horizons Ventures
Key Investors in BlueDot
The Co-operators
An undisclosed investor participating in the funding round.
BDC Capital
Massachusetts Business Development Corp. provides supplemental financing and financial services to growing companies in Massachusetts, offering equity investments, loans, and guarantees.
Horizons Ventures
Horizons Ventures partners have a long history of assisting entrepreneurs in transforming startup ventures into successful companies, actively engaging with founders who possess compelling and pragmatic visions.
What's next for BlueDot?
With this major strategic investment, BlueDot is poised for accelerated growth and enhanced global reach. The capital infusion is expected to fuel further development of its AI-driven disease surveillance capabilities and expand its market penetration. This funding round signifies a pivotal moment, enabling BlueDot to strengthen its role as a leader in proactive global health security and pandemic preparedness, reinforcing its mission to mitigate the impact of infectious diseases worldwide.
See full BlueDot company page
